Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,613 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
MercadoLibre reports 40% year-over-year growth fueled by fintech expansion and a resilient e-commerce network in Lati...
Palantir has moved from hero to a pullback phase. This guide breaks down what its valuation says about the future, wi...
As market conditions shift in 2026, a $1 million retirement near Sarasota’s beaches can work—with careful budgeting, ...
Axcelis Technologies has seen its stock surge this year, riding AI-chip demand. This guide breaks down what the compa...
Memory stocks kicked higher Monday, led by SanDisk and Western Digital, as banks turn constructive on the sector. Ana...
Shoppers grapple with dopamine-driven triggers as online shopping experiences mimic the thrill of a sale without tapp...
Meta unveils a sweeping 5-GW AI data center expansion in rural Louisiana, widening a rift over economic benefits and ...
Oklo stock has faced big swings, but analysts see a potential upside. This guide breaks down what the projection to $...
Headwinds have pressured Vornado, but two strategic catalysts could unlock meaningful upside. This guide breaks down ...
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...
Freddie Mac reports mortgage rates fall below 6% this week for the first time since 2022, signaling relief for buyers...